Clinical Trials Directory

Trials / Completed

CompletedNCT06139380

Intranasal Ketamine Effectiveness in Reducing Intramuscular Injection Pain Before Sedation Among Children

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Tehran University of Medical Sciences · Academic / Other
Sex
All
Age
12 Months – 7 Years
Healthy volunteers
Not accepted

Summary

Hypothesis: Intranasal administration of ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department.

Detailed description

Ketamine is a well-known medication in children's procedural sedation and analgesia. While it provides good analgesia along with sedation, its injection is painful and causes distress in children. Intranasal administration of Ketamine would reduce the intramuscular pain of ketamine injection in children who undergo procedural sedation and analgesia in the emergency department. This will also assess if intranasal administration would affect the depth of sedation and hospital length of stay of this group of patients.

Conditions

Interventions

TypeNameDescription
DRUGKetamineThis is medication which is commonly used for sedation in the emergency department. At the analgesic dose, this medication can be used to reduce the pain via other routes such as intranasal.
DRUGSterile waterIntranasal sterile water was administered via syringe.

Timeline

Start date
2023-12-02
Primary completion
2024-04-28
Completion
2024-05-31
First posted
2023-11-18
Last updated
2024-06-04

Locations

1 site across 1 country: Iran

Source: ClinicalTrials.gov record NCT06139380. Inclusion in this directory is not an endorsement.